• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用氟代胸苷正电子发射断层扫描(FLT PET)对功能性骨盆骨髓进行空间映射。

Spatial mapping of functional pelvic bone marrow using FLT PET.

作者信息

McGuire Sarah M, Menda Yusuf, Ponto Laura L Boles, Gross Brandie, TenNapel Mindi, Smith Brian J, Bayouth John E

机构信息

University of Iowa.

出版信息

J Appl Clin Med Phys. 2014 Jul 8;15(4):129–136. doi: 10.1120/jacmp.v15i4.4780.

DOI:10.1120/jacmp.v15i4.4780
PMID:25207403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4161980/
Abstract

The purpose of this study was to determine the ability of regions identified with bony landmarks on CT imaging to accurately represent active bone marrow when compared to FLT PET imaging. These surrogate regions could then be used to create a bone marrow sparing radiation therapy plan when FLT PET imaging is not available. Whole body (WB) FLT PET images were obtained of 18 subjects prior to chemoradiation therapy. The FLT image of each subject was registered to a CT image acquired for that subject to obtain anatomic information of the pelvis. Seventeen regions were identified based on features of the pelvic bones, sacrum, and femoral heads. The probability of FLT uptake being located in each of 17 different CT-based regions of the bony pelvis was calculated using Tukey's multiple comparison test. Statistical analysis of FLT uptake in the pelvis indicated four distinct groups within the 17 regions that had similar levels of activity. Regions located in the central part of the pelvis, including the superior part of the sacrum, the inner halves of the iliac crests, and the L5 vertebral body, had greater FLT uptake than those in the peripheral regions (p-value < 0.05). We have developed a method to use CT-defined pelvic bone regions to represent FLT PET-identified functional bone marrow. Individual regions that have a statistically significant probability of containing functional bone marrow can be used as avoidance regions to reduce radiation dose to functional bone marrow in radiation therapy planning. However, because likely active bone marrow regions and pelvic targets typically overlap, patient-specific spatial detail may be advantageous in IMRT planning scenarios and may best be provided using FLT PET imaging.

摘要

本研究的目的是确定在CT成像上用骨性标志识别的区域与FLT PET成像相比,准确代表活跃骨髓的能力。当无法获得FLT PET成像时,这些替代区域可用于制定骨髓保护放疗计划。在放化疗前,对18名受试者进行了全身(WB)FLT PET成像。将每个受试者的FLT图像与该受试者获取的CT图像配准,以获得骨盆的解剖信息。根据骨盆骨、骶骨和股骨头的特征确定了17个区域。使用Tukey多重比较检验计算FLT摄取位于骨盆17个不同CT区域中每个区域的概率。对骨盆中FLT摄取的统计分析表明,17个区域内有四个不同的组,其活性水平相似。位于骨盆中部的区域,包括骶骨上部、髂嵴内半部和L5椎体,其FLT摄取高于周边区域(p值<0.05)。我们已经开发出一种方法,使用CT定义的骨盆骨区域来代表FLT PET识别的功能性骨髓。在放疗计划中,具有统计学显著概率包含功能性骨髓的各个区域可作为避让区域,以减少对功能性骨髓的辐射剂量。然而,由于可能的活跃骨髓区域和盆腔靶区通常重叠,在IMRT计划方案中,患者特异性的空间细节可能具有优势,并且最好使用FLT PET成像来提供。

相似文献

1
Spatial mapping of functional pelvic bone marrow using FLT PET.使用氟代胸苷正电子发射断层扫描(FLT PET)对功能性骨盆骨髓进行空间映射。
J Appl Clin Med Phys. 2014 Jul 8;15(4):129–136. doi: 10.1120/jacmp.v15i4.4780.
2
A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy.一种将功能性骨髓保护纳入骨盆放射治疗调强放疗计划的方法。
Radiother Oncol. 2011 Apr;99(1):49-54. doi: 10.1016/j.radonc.2011.01.025. Epub 2011 Mar 22.
3
Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.利用正电子发射断层扫描成像的[18F]氟代胸苷来量化并降低盆腔癌患者放化疗所致的血液学毒性。
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):228-39. doi: 10.1016/j.ijrobp.2016.04.009. Epub 2016 Apr 19.
4
3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.放射性骨髓损伤 3'-脱氧-3'-[¹⁸F]氟代胸苷 PET 定量评估
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):888-93. doi: 10.1016/j.ijrobp.2010.12.009. Epub 2011 Feb 6.
5
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.FLT-PET/CT 影像学测量非小细胞肺癌患者增殖骨髓的分布图谱及其在放射治疗计划中的潜在适用性
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1035-1043. doi: 10.1016/j.ijrobp.2015.04.027. Epub 2015 Apr 22.
6
[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.[18F]氟代-2-脱氧-2-D-葡萄糖与3'-脱氧-3'-[18F]氟代胸苷用于确定妇科患者中具有造血活性的盆腔骨髓
Radiother Oncol. 2016 Jan;118(1):72-8. doi: 10.1016/j.radonc.2015.11.018. Epub 2015 Dec 7.
7
Incorporating FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.将 FDG-PET 定义的骨盆活性骨髓纳入接受放化疗的肛门癌患者自动治疗计划过程中。
BMC Cancer. 2017 Nov 2;17(1):710. doi: 10.1186/s12885-017-3708-4.
8
Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.使用18F-FLT PET/CT和超顺磁性氧化铁磁共振成像(USPIO MRI)在大鼠模型中对骨髓辐射损伤与恢复情况进行成像
J Nucl Med. 2016 Feb;57(2):266-71. doi: 10.2967/jnumed.115.158121. Epub 2015 Aug 27.
9
Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.利用 FLT-PET 成像测定成年癌症患者增殖骨髓的分布。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):847-52. doi: 10.1016/j.ijrobp.2009.11.040. Epub 2010 May 14.
10
18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.18F-FLT正电子发射断层显像在血液系统疾病中的应用:一种分析骨髓腔的新技术
J Nucl Med. 2006 Oct;47(10):1592-8.

引用本文的文献

1
A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer.一项前瞻性单臂研究,探讨子宫颈/子宫内膜癌调强放疗联合或不联合同期化疗时盆腔功能性骨髓剂量-体积参数与急性血液学毒性的关系。
Radiat Oncol. 2023 Nov 27;18(1):193. doi: 10.1186/s13014-023-02380-8.
2
Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial.采用骨髓保护调强放疗对肛管癌患者进行同步放化疗:一项前瞻性II期试验的最终结果
J Pers Med. 2021 May 18;11(5):427. doi: 10.3390/jpm11050427.
3

本文引用的文献

1
Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.RTOG0418 中的血液学毒性:妇科癌症术后调强放疗的 2 期研究。
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):83-90. doi: 10.1016/j.ijrobp.2013.01.017.
2
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.前瞻性研究功能性骨髓保护调强放疗联合化疗治疗盆腔恶性肿瘤。
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):406-14. doi: 10.1016/j.ijrobp.2012.04.044. Epub 2012 Jun 9.
3
A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy.
Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial.接受同步放化疗的肛管癌患者的骨髓保护调强放疗:一项前瞻性II期试验第一阶段的结果
Cancers (Basel). 2020 Nov 9;12(11):3306. doi: 10.3390/cancers12113306.
4
A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.多图谱法在主动骨髓保护放疗中的应用:NRG-GY006 试验中的实施。
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1240-1247. doi: 10.1016/j.ijrobp.2020.06.071. Epub 2020 Jul 3.
5
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.盆腔骨骨髓对同步放化疗治疗肛门癌的 FDG 摄取反应。
Radiother Oncol. 2020 Feb;143:19-23. doi: 10.1016/j.radonc.2019.08.016. Epub 2019 Sep 7.
6
Incorporating FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.将 FDG-PET 定义的骨盆活性骨髓纳入接受放化疗的肛门癌患者自动治疗计划过程中。
BMC Cancer. 2017 Nov 2;17(1):710. doi: 10.1186/s12885-017-3708-4.
7
Copper-64 labeled liposomes for imaging bone marrow.用于骨髓成像的铜-64标记脂质体。
Nucl Med Biol. 2016 Dec;43(12):781-787. doi: 10.1016/j.nucmedbio.2016.08.011. Epub 2016 Aug 27.
8
Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.利用正电子发射断层扫描成像的[18F]氟代胸苷来量化并降低盆腔癌患者放化疗所致的血液学毒性。
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):228-39. doi: 10.1016/j.ijrobp.2016.04.009. Epub 2016 Apr 19.
9
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.以FDG-PET定义的盆腔骨髓特定亚区域剂量作为肛管癌患者同步放化疗期间血液学最低点的预测指标。
Med Oncol. 2016 Jul;33(7):72. doi: 10.1007/s12032-016-0789-x. Epub 2016 Jun 8.
10
[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.[18F]氟代-2-脱氧-2-D-葡萄糖与3'-脱氧-3'-[18F]氟代胸苷用于确定妇科患者中具有造血活性的盆腔骨髓
Radiother Oncol. 2016 Jan;118(1):72-8. doi: 10.1016/j.radonc.2015.11.018. Epub 2015 Dec 7.
一种将功能性骨髓保护纳入骨盆放射治疗调强放疗计划的方法。
Radiother Oncol. 2011 Apr;99(1):49-54. doi: 10.1016/j.radonc.2011.01.025. Epub 2011 Mar 22.
4
Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer.贝伐珠单抗、奥沙利铂、氟尿嘧啶和放疗治疗直肠癌。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):124-9. doi: 10.1016/j.ijrobp.2010.08.005. Epub 2010 Oct 13.
5
Review of chemoradiotherapy for high-risk prostate cancer.高危前列腺癌的放化疗综述
Rev Recent Clin Trials. 2011 Jan;6(1):64-8. doi: 10.2174/157488711793980200.
6
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial.多中心Ⅱ期临床试验:同步及辅助多西他赛联合三维适形放疗加雄激素剥夺治疗高危前列腺癌:初步结果。
Radiother Oncol. 2010 Nov;97(2):312-7. doi: 10.1016/j.radonc.2010.08.012. Epub 2010 Sep 16.
7
Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.头颈部癌放化疗开始前后骨髓中 3'-去氧-3'-[18F]氟胸苷摄取的药代动力学研究。
Nucl Med Biol. 2010 May;37(4):433-8. doi: 10.1016/j.nucmedbio.2010.02.005.
8
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.局部晚期宫颈癌的放化疗:顺铂剂量及其他临床预后因素分析。
Gynecol Oncol. 2010 Mar;116(3):438-41. doi: 10.1016/j.ygyno.2009.09.045. Epub 2009 Nov 5.
9
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.骨髓保护调强放疗与传统技术治疗宫颈癌的剂量学比较
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1504-10. doi: 10.1016/j.ijrobp.2008.04.046.
10
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.同步放化疗联合调强放疗治疗的肛管癌患者骨髓剂量学参数与急性血液学毒性的相关性
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1431-7. doi: 10.1016/j.ijrobp.2007.08.074. Epub 2007 Nov 8.